Aurora Private Wealth Inc. Acquires New Shares in Zoetis Inc. (NYSE:ZTS)

Aurora Private Wealth Inc. bought a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 14,498 shares of the company's stock, valued at approximately $2,387,000.

Other large investors have also modified their holdings of the company. Mission Wealth Management LP grew its stake in Zoetis by 2.0% during the 4th quarter. Mission Wealth Management LP now owns 2,938 shares of the company's stock valued at $479,000 after purchasing an additional 59 shares in the last quarter. HUB Investment Partners LLC lifted its holdings in shares of Zoetis by 4.7% in the 4th quarter. HUB Investment Partners LLC now owns 1,373 shares of the company's stock worth $224,000 after purchasing an additional 62 shares during the last quarter. Coppell Advisory Solutions LLC lifted its holdings in shares of Zoetis by 18.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 420 shares of the company's stock worth $68,000 after purchasing an additional 64 shares during the last quarter. Lindbrook Capital LLC lifted its holdings in shares of Zoetis by 1.8% in the 4th quarter. Lindbrook Capital LLC now owns 3,650 shares of the company's stock worth $595,000 after purchasing an additional 65 shares during the last quarter. Finally, Ironwood Investment Management LLC lifted its holdings in shares of Zoetis by 0.8% in the 4th quarter. Ironwood Investment Management LLC now owns 8,354 shares of the company's stock worth $1,361,000 after purchasing an additional 68 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ZTS shares. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and cut their price target for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. UBS Group cut their target price on Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. Finally, Piper Sandler lifted their target price on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, May 12th. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $212.13.

Zoetis Price Performance

Shares of ZTS stock traded down $2.20 during mid-day trading on Monday, hitting $156.98. 2,822,512 shares of the stock traded hands, compared to its average volume of 2,573,770. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $200.33. The firm has a market cap of $69.89 billion, a price-to-earnings ratio of 28.18, a price-to-earnings-growth ratio of 2.64 and a beta of 0.91. The company's 50-day simple moving average is $161.16 and its 200-day simple moving average is $162.08. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion for the quarter, compared to analysts' expectations of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. During the same period last year, the firm earned $1.38 EPS. As a group, equities research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis's payout ratio is 35.91%.

Insider Activity

In related news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president directly owned 15,129 shares in the company, valued at $2,571,930. The trade was a 4.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.16% of the stock is owned by insiders.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.